Biologic and clinical significance of molecular profiling in Chronic Lymphocytic Leukemia
- 15 April 2010
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 24 (3) , 135-141
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Improved survival in chronic lymphocytic leukemia in the past decade: a population-based study including 11,179 patients diagnosed between 1973-2003 in SwedenHaematologica, 2009
- Rediscovering alemtuzumab: current and emerging therapeutic rolesBritish Journal of Haematology, 2009
- Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIABlood, 2008
- Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemiaBlood, 2008
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelinesBlood, 2008
- Use of IGHV3–21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post–germinal center leukemogenic selectionBlood, 2008
- MiR-15a and miR-16-1 cluster functions in human leukemiaProceedings of the National Academy of Sciences, 2008
- Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic LeukemiaJournal of Clinical Oncology, 2005
- ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profileBlood, 2003
- Cellular Origin of Human B-Cell LymphomasNew England Journal of Medicine, 1999